Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Fatty15 Launches Practitioner-Exclusive C15:0 Supplement - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

Fatty15 Launches Practitioner-Exclusive C15:0 Supplement

The essential fatty acid, the first of its kind discovered in 90 years, is thought to support measures of cardiovascular and metabolic health.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Seraphina Therapeutics, Inc., the maker of the fatty15 supplement, has launched a practitioner-exclusive, high-dose version of the C15:0 supplement, which is available through FullScript, a platform used by more than 125,000 practitioners to acquire professional-grade supplements.  

“Fullscript’s deep roots in the provider community make them an exceptional partner to launch Fatty15 Advanced Formula Extra Strength,” said Dr. Eric Venn-Watson, co-founder and co-CEO of Seraphina Therapeutics. “Together, we share a commitment to delivering the highest-quality, science-backed solutions to clinicians who are driving better outcomes for their patients every day.”

The supplement, Fatty15 Advanced Formula Extra Strength, delivers a potent dose of pure C15:0, the first essential fatty acid to be discovered in 90 years.

According to the company, peer-reviewed studies suggest that low C15:0 levels may lead to ferroptosis, a newly discovered form of cell death that accelerates aging, impacting liver, metabolic, heart, cognitive, and red blood cell health. Optimal C15:0 levels have been associated with better cardiovascular and metabolic health outcomes in prospective human studies, the company noted.

Fatty15 Advanced Formula Extra Strength was developed to achieve and maintain optimal C15:0 levels in patients with the goal of delivering measurable benefits in biomarkers of aging within months.

C15:0 was first discovered by Seraphina’s co-founder, Stephanie Venn-Watson, DVM. While serving as a veterinary epidemiologist for the U.S. Navy, she discovered that several Navy dolphins were developing aging-associated conditions. Using metabolomics, they realized that C15:0, among hundreds of other serum-based molecules, was the strongest predictor of the healthiest dolphins. Over the next decade, more than 100 peer-reviewed studies have been published in C15:0.

An independent third-party panel reviewed the totality of data on C15:0, and concluded that the supplement’s claims are backed by competent and reliable scientific evidence (CARSE), Seraphina Therapeutics reported.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics